143 related articles for article (PubMed ID: 28163134)
21. Hot melt extruded transdermal films based on amorphous solid dispersions in Eudragit RS PO: The inclusion of hydrophilic additives to develop moisture-activated release systems.
Albarahmieh E; Qi S; Craig DQM
Int J Pharm; 2016 Nov; 514(1):270-281. PubMed ID: 27863672
[TBL] [Abstract][Full Text] [Related]
22. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions.
Andrews GP; AbuDiak OA; Jones DS
J Pharm Sci; 2010 Mar; 99(3):1322-35. PubMed ID: 19798757
[TBL] [Abstract][Full Text] [Related]
23. Designing and characterizing of tramadol hydrochloride transdermal patches prepared with Ficus carica fruit mucilage and povidone.
Ahad HA; Ishaq BM; Shaik M; Bandagisa F
Pak J Pharm Sci; 2016 May; 29(3):945-51. PubMed ID: 27166538
[TBL] [Abstract][Full Text] [Related]
24. Silicone adhesive, a better matrix for tolterodine patches-a research based on in vitro/in vivo studies.
Liu J; Wang Z; Liu C; Xi H; Li C; Chen Y; Sun L; Mu L; Fang L
Drug Dev Ind Pharm; 2012 Aug; 38(8):1008-14. PubMed ID: 22126709
[TBL] [Abstract][Full Text] [Related]
25. Drug recrystallization in drug-in-adhesive transdermal delivery system: A case study of deteriorating the mechanical and rheological characteristics of testosterone TDS.
Mohamed LA; Kamal N; Elfakhri KH; Willett D; Wokovich A; Strasinger C; Cruz CN; Raney SG; Ashraf M; Zidan AS
Int J Pharm; 2020 Mar; 578():119132. PubMed ID: 32057892
[TBL] [Abstract][Full Text] [Related]
26. Influence of PVP/VA copolymer composition on drug-polymer solubility.
Rask MB; Knopp MM; Olesen NE; Holm R; Rades T
Eur J Pharm Sci; 2016 Mar; 85():10-7. PubMed ID: 26826280
[TBL] [Abstract][Full Text] [Related]
27. Influence of polymer content on stabilizing milled amorphous salbutamol sulphate.
Balani PN; Wong SY; Ng WK; Widjaja E; Tan RB; Chan SY
Int J Pharm; 2010 May; 391(1-2):125-36. PubMed ID: 20211717
[TBL] [Abstract][Full Text] [Related]
28. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
Caron V; Tajber L; Corrigan OI; Healy AM
Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
[TBL] [Abstract][Full Text] [Related]
29. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
Dhumal RS; Shimpi SL; Paradkar AR
Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
[TBL] [Abstract][Full Text] [Related]
30. Drug in adhesive patch of palonosetron: Effect of pressure sensitive adhesive on drug skin permeation and in vitro-in vivo correlation.
Liu C; Hui M; Quan P; Fang L
Int J Pharm; 2016 Sep; 511(2):1088-97. PubMed ID: 27521703
[TBL] [Abstract][Full Text] [Related]
31. Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility.
Marsac PJ; Shamblin SL; Taylor LS
Pharm Res; 2006 Oct; 23(10):2417-26. PubMed ID: 16933098
[TBL] [Abstract][Full Text] [Related]
32. Mixture design approach for early stage formulation development of a transdermal delivery system.
Michaelis M; Leopold CS
Drug Dev Ind Pharm; 2015; 41(9):1532-40. PubMed ID: 25308745
[TBL] [Abstract][Full Text] [Related]
33. Impact of Different Mixing Methods on the Performance of Suspension-Based Transdermal Delivery Systems.
Bhattaccharjee SA; Kale M; Le N; Banga AK
AAPS PharmSciTech; 2021 May; 22(4):150. PubMed ID: 33973096
[TBL] [Abstract][Full Text] [Related]
34. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions.
Ghebremeskel AN; Vemavarapu C; Lodaya M
Pharm Res; 2006 Aug; 23(8):1928-36. PubMed ID: 16871443
[TBL] [Abstract][Full Text] [Related]
35. Recrystallization of nifedipine and felodipine from amorphous molecular level solid dispersions containing poly(vinylpyrrolidone) and sorbed water.
Marsac PJ; Konno H; Rumondor AC; Taylor LS
Pharm Res; 2008 Mar; 25(3):647-56. PubMed ID: 17846870
[TBL] [Abstract][Full Text] [Related]
36. Can biologically inspired patches yield a new age of transdermal delivery?
Chang CC
Ther Deliv; 2014 Apr; 5(4):373-5. PubMed ID: 24856163
[No Abstract] [Full Text] [Related]
37. Effect of Chemical Penetration Enhancer-Adhesive Interaction on Drug Release from Transdermal Patch: Mechanism Study Based on FT-IR Spectroscopy,
Luo Z; Liu C; Quan P; Zhang Y; Fang L
AAPS PharmSciTech; 2021 Jun; 22(5):198. PubMed ID: 34195881
[TBL] [Abstract][Full Text] [Related]
38. The role of carboxyl group of pressure sensitive adhesive in controlled release of propranolol in transdermal patch: Quantitative determination of ionic interaction and molecular mechanism characterization.
Yang D; Wan X; Quan P; Liu C; Fang L
Eur J Pharm Sci; 2018 Mar; 115():330-338. PubMed ID: 29414309
[TBL] [Abstract][Full Text] [Related]
39. Mechanistic insights into the effect of drug content on adhesive properties of transdermal patch containing lidocaine.
Wang M; Zhang Y; Li M; Zhao N; Luo Z
Eur J Pharm Sci; 2023 May; 184():106419. PubMed ID: 36878407
[TBL] [Abstract][Full Text] [Related]
40. Recent developments in silicones for topical and transdermal drug delivery.
Aliyar H; Schalau G
Ther Deliv; 2015 Jul; 6(7):827-39. PubMed ID: 26228774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
